Cite
HARVARD Citation
Wang, P. et al. (2014). Effects and Safety of Allogenic Mesenchymal Stem Cell Intravenous Infusion in Active Ankylosing Spondylitis Patients who Failed NSAIDs: A 20-Week Clinical Trial. Cell transplantation. 23 (10), pp. 1293-1303. [Online].